p16 Not a Prognostic Marker for Hypopharyngeal Squamous Cell Carcinoma
Author(s) -
David D. Wilson,
Asal Rahimi,
Drew K. Saylor,
Edward B. Stelow,
Mark J. Jameson,
David C. Shonka,
James F. Reibel,
Paul A. Levine,
Paul W. Read
Publication year - 2012
Publication title -
archives of otolaryngology - head and neck surgery
Language(s) - English
Resource type - Journals
eISSN - 1538-361X
pISSN - 0886-4470
DOI - 10.1001/archoto.2012.950
Subject(s) - medicine , oncology , immunohistochemistry , biopsy , radiation therapy , clinical significance , biomarker , biochemistry , chemistry
To investigate the prognostic significance of p16 in patients with hypopharyngeal squamous cell carcinoma (HPSCC) and to evaluate the relationship between p16 and human papillomavirus (HPV). Unlike in oropharyngeal SCC (OPSCC), the prognostic significance of p16 in HPSCC and its association with HPV is unclear.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom